You are here: Industry Insights > COVID-19

News List

Dalmia Healthcare nod from AYUSH Ministry to manufacture Astha-15 for COVID-19 treatment expresspharma
November 11, 2020
Dalmia Healthcare would be applying for permission/approval of Astha-15 usage in allopathic hospitals, as per the procedure in each hospital.
Indian scientists working on effective vaccines against COVID-19 and HIV: IISC expresspharma
November 11, 2020
The studies were published in the Journal of Biological Chemistry and the Proceedings of the National Academy of Sciences.
US to begin distribution of Bamlanivimab, COVID-19 antibody from Eli Lilly expresspharma
November 11, 2020
Bamlanivimab allocations to states and territories will be based on their number of hospitalised COVID-19 patients and the number of overall cases, informed government officials.
Novartis provides update on CAN-COVID trial in hospitalized patients with COVID-19 pneumonia and cytokine release syndrome (CRS) worldpharmanews
November 10, 2020
Novartis announced new data from an interim analysis for the randomized, double-blind, placebo-controlled CAN-COVID trial evaluating the efficacy and safety of canakinumab in hospitalized patients with COVID-19 pneumonia and cytokine release syndrome.
Llama nanobodies could be a powerful weapon against COVID-19 worldpharmanews
November 10, 2020
The researchers at the University of Pittsburgh School of Medicine describe a new method to extract tiny but extremely powerful SARS-CoV-2 antibody fragments from llamas, which could be fashioned into inhalable therapeutics with the potential to ...
Differences in remdesivir efficacy due to trial variances, not drug, report says europeanpharmaceuticalreview
November 10, 2020
After remdesivir showed little effect against COVID-19 in the SOLIDARITY trial, a new report has suggested this is due to the structure of the study.
First patient dosed in COVID-19 trial with allogeneic cell therapy europeanpharmaceuticalreview
November 10, 2020
The first patient with COVID-19 has been administered agenT-797, an allogeneic cell therapy made by Agenus Inc.
Joe Biden advisers and drug firms hold talks on OWS before US election pharmaceutical-technology
November 10, 2020
Healthcare advisers of US President-elect Joe Biden held discussions with pharma companies before the US election on the government’s Operation Warp Speed (OWS) programme to boost the development of a potential Covid-19 treatment.
Australia to initiate manufacturing of vaccine candidate for Covid-19 pharmaceutical-technology
November 10, 2020
Australia is planning to commence the manufacturing of Covid-19 vaccine candidate, AZD1222, at biotech firm CSL’s advanced manufacturing facility in Broadmeadows, Victoria.
Humanigen signs Covid-19 therapy development deal with US pharmaceutical-technology
November 10, 2020
Humanigen has signed an agreement with the US Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) to develop lenzilumab for Covid-19 treatment.